Canton Hathaway’s AbbVie ABBV Stock Holding History

Canton Hathaway’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$334K	Hold	1,326	–	–	0.06%	103
2026 Q1	$288K	Sell	1,326 -150	-10%	-$33.3K	0.06%	114
2025 Q4	$337K	Sell	1,476 -16	-1%	-$3.65K	0.07%	106
2025 Q3	$345K	Hold	1,492	–	–	0.07%	117
2025 Q2	$277K	Buy	1,492 +16	+1%	+$2.97K	0.06%	125
2025 Q1	$309K	Hold	1,476	–	–	0.06%	119
2024 Q4	$262K	Hold	1,476	–	–	0.07%	91
2024 Q3	$291K	Hold	1,476	–	–	0.07%	84
2024 Q2	$253K	Hold	1,476	–	–	0.07%	85
2024 Q1	$269K	Hold	1,476	–	–	0.07%	87
2023 Q4	$229K	Hold	1,476	–	–	0.07%	87
2023 Q3	$220K	Hold	1,476	–	–	0.07%	89
2023 Q2	$199K	Sell	1,476 -100	-6%	-$14.7K	0.06%	95
2023 Q1	$251K	Hold	1,576	–	–	0.09%	79
2022 Q4	$255K	Hold	1,576	–	–	0.09%	78
2022 Q3	$212K	Sell	1,576 -31	-2%	-$4.45K	0.08%	92
2022 Q2	$246K	Sell	1,607 -134	-8%	-$20.5K	0.09%	93
2022 Q1	$282K	Buy	1,741 +1	+0.1%	+$145	0.08%	95
2021 Q4	$236K	Hold	1,740	–	–	0.06%	106
2021 Q3	$188K	Buy	1,740 +1,001	+135%	+$114K	0.05%	114
2021 Q2	$83K	Buy	739 +158	+27%	+$17.8K	0.02%	136
2021 Q1	$63K	Buy	581 +431	+287%	+$46.1K	0.02%	150
2020 Q4	$16K	Buy	+150	New	+$14.4K	0.01%	204
2019 Q4	–	Sell	-130	Closed	-$10K	–	200
2019 Q3	$10K	Hold	130	–	–	0.01%	183
2019 Q2	$9K	Hold	130	–	–	0.01%	209
2019 Q1	$10K	Buy	+130	New	+$10.6K	0.01%	210

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Canton Hathaway's ABBV Position: Q2 2026 in Review

Canton Hathaway held its AbbVie (ABBV) position steady in Q2 2026 at 1,326 shares worth $334K. The position accounts for 0.06% of the portfolio, ranked #103.

Canton Hathaway first reported a position in ABBV in Q1 2019 and has held it in 26 quarters since. The position peaked at $345K in Q3 2025. 4,192 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Canton Hathaway held 1,326 shares of AbbVie worth $334K as of Q2 2026.
Canton Hathaway left its AbbVie share count unchanged in Q2 2026.
AbbVie made up 0.06% of Canton Hathaway's portfolio in Q2 2026, its #103 holding.
Canton Hathaway first reported a position in AbbVie in Q1 2019 and has held it in 26 quarters since.
Canton Hathaway's AbbVie position peaked at $345K in Q3 2025.
4,192 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Canton Hathaway's 13F filing for Q2 2026, filed 6 Aug 2026.